Aliases:This biomarker is also known as:
- DiGeorge syndrome critical region protein 6,
- DiGeorge syndrome critical region 6,
- protein DGCR6,
- DiGeorge syndrome critical region gene 6,
DGCR6 is located on chromosome 22q11.21. Microdeletions in this region are associated with DiGeorge syndrome, and more widely, the CATCH 22 syndrome. DGCR6, also known as DiGeorge syndrome critical region 6, is thought to be involved in DiGeorge syndrome pathology and in schizophrenia. Another function attributed to this gene is a role in neural crest cell migration into the third and fourth pharyngeal pouches. The DGCR6 protein shares homology with the Drosophila melanogaster gonadal protein, which participates in gonadal and germ cell development, and with the gamma-1 subunit of human laminin.
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
|QA State:||Under Review|
No additional breast data available.
DGCR6 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.
- Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.
- Development and validation of sandwich ELISA microarrays with minimal assay interference.
- Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.